# reload+after+2024-01-20 01:38:27.746882
address1§10710 Midlothian Turnpike
city§North Chesterfield
state§VA
zip§23235
country§United States
phone§804 379 1090
website§https://www.indivior.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
fullTimeEmployees§1000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Mark  Crossley', 'title': 'CEO & Executive Director', 'fiscalYear': 2022, 'totalPay': 1657969, 'exercisedValue': 0, 'unexercisedValue': 2793902}, {'maxAge': 1, 'name': 'Mr. Ryan  Preblick', 'title': 'CFO & Executive Director', 'fiscalYear': 2022, 'totalPay': 814524, 'exercisedValue': 0, 'unexercisedValue': 109556}, {'maxAge': 1, 'name': 'Dr. Christian  Heidbreder', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason  Thompson', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Cynthia  Cetani', 'title': 'Chief Integrity & Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey W. Burris', 'age': 51, 'title': 'Chief Legal Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jon  Fogle', 'title': 'Chief Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard  Simkin', 'title': 'Chief Commercial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hillel  West', 'title': 'Chief Manufacturing & Supply Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nina  DeLorenzo', 'title': 'Chief Global Impact Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§3
compensationRisk§8
shareHolderRightsRisk§1
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
exDividendDate§1466035200
payoutRatio§0.0
beta§-0.082
priceToSalesTrailing12Months§1.5529151
currency§GBp
forwardEps§1.46
pegRatio§-3.23
exchange§LSE
quoteType§EQUITY
shortName§INDIVIOR PLC ORD USD0.50
longName§Indivior PLC
firstTradeDateEpochUtc§1419235200
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§c73f311f-be88-3258-8a95-94ad4d61c2b1
targetHighPrice§26.87
targetLowPrice§21.54
targetMeanPrice§24.43
targetMedianPrice§24.88
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§0.793
grossMargins§0.83301
ebitdaMargins§0.24472
trailingPegRatio§None
